You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TG-2349

Showing 1 - 25 of 378
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Hepatics C Virus (HCV) Genotype 1, Non-Cirrhotic, Cirrhosis Trial in Beijing (non-cirrhotic subjects. low TG-2349+ low

Completed
  • Chronic Hepatics C Virus (HCV) Genotype 1
  • +3 more
  • non-cirrhotic subjects. low TG-2349+ low DAG181+Ribavirin
  • +5 more
  • Beijing, Beijing, China
    Peking University Peoples Hospital
Feb 16, 2021

Chronic Hepatics C Virus (HCV) Genotype 1, Non-Cirrhotic, Cirrhosis Trial in Beijing (TG-2349, DAG181, Ribavirin)

Completed
  • Chronic Hepatics C Virus (HCV) Genotype 1
  • +3 more
  • TG-2349
  • +2 more
  • Beijing, China
    Beijing Tsinghua Changgung Hospital
Feb 2, 2021

Hepatitis C, Chronic Trial in Kaohsiung (TG-2349, Ribavirin, Interferon Alfa-2a)

Completed
Has Results
  • Hepatitis C, Chronic
  • TG-2349
  • +2 more
  • Kaohsiung, Taiwan
    Kaohsiung Medical University Chung-Ho Memorial Hospital
Sep 11, 2018

Healthy Chinese Volunteers Trial in Changsha (TG-2349 (400 mg) plus DAG181 (200 mg), DAG181 (200 mg) plus TG-2349 (400 mg))

Completed
  • Healthy Chinese Volunteers
  • TG-2349 (400 mg) plus DAG181 (200 mg)
  • DAG181 (200 mg) plus TG-2349 (400 mg)
  • Changsha, Hunan, China
    Xiangya Hospital Central South University
Jul 26, 2018

Healthy Chinese Volunteers Trial in Changsha (Furaprevir capsule (SAD), Furaprevir capsule (MAD), Placebo (SAD))

Completed
  • Healthy Chinese Volunteers
  • Furaprevir capsule (SAD)
  • +3 more
  • Changsha, Hunan, China
    Xiangya Hospital Central South University
Aug 1, 2018

Pharmacokinetics Trial (WCK 2349 Oral, Placebo Oral)

Completed
  • Pharmacokinetics
  • WCK 2349 Oral
  • Placebo Oral
  • (no location specified)
Nov 28, 2022

High Triglycerides Trial (NST-1024, Placebo)

Not yet recruiting
  • High Triglycerides
  • (no location specified)
May 25, 2023

Thyroglobulin Point of Care Assay for Rapid Detection of

Recruiting
  • Differentiated Thyroid Cancer
  • Lymph Node Metastases
  • Point of care assay for thyroglobulin (POC-Tg) evaluation of a suspected cervical lymph node
  • Ashkelon, Israel
  • +2 more
Oct 25, 2022

HPV Infection, Sexually Transmitted Infections and Anal

Not yet recruiting
  • Human Papillomavirus Infection
  • +2 more
    • (no location specified)
    Aug 1, 2023

    B-Cell Lymphoma Trial in Heidelberg, Melbourne, Nedlands (TG-1801, Ublituximab)

    Active, not recruiting
    • B-Cell Lymphoma
    • Heidelberg, Victoria, Australia
    • +2 more
    Jan 20, 2023

    Severe Hypertriglyceridemia Trial (Pegozafermin, Placebo)

    Not yet recruiting
    • Severe Hypertriglyceridemia
    • (no location specified)
    May 2, 2023

    Degenerative Osteoarthritis Trial (TG-C, Placebo Control)

    Not yet recruiting
    • Degenerative Osteoarthritis
    • TG-C
    • Placebo Control
    • (no location specified)
    Dec 22, 2022

    Acceptability ofPrEP Program Among MSM and Transgender and

    Not yet recruiting
    • HIV Infections
    • STI
    • acceptability of a PrEP program among HIV-negative MSM and TG
    • (no location specified)
    Jul 10, 2023

    CLL, SLL, Richter's Transformation Trial in United States (TG-1801, Ublituximab)

    Recruiting
    • CLL
    • +9 more
    • TG-1801
    • Ublituximab
    • Fayetteville, Arkansas
    • +4 more
    Jan 20, 2023

    Severe Hypertriglyceridemia Trial in Canada, United States (Olezarsen, Placebo)

    Recruiting
    • Severe Hypertriglyceridemia
    • Birmingham, Alabama
    • +24 more
    Jan 25, 2023

    Severe Hypertriglyceridemia Trial in Worldwide (Olezarsen, Placebo)

    Recruiting
    • Severe Hypertriglyceridemia
    • Chula Vista, California
    • +109 more
    Jan 23, 2023

    Degenerative Osteoarthritis Trial in United States (TG-C, Placebo Control)

    Recruiting
    • Degenerative Osteoarthritis
    • TG-C
    • Placebo Control
    • Birmingham, Alabama
    • +34 more
    Dec 23, 2022

    Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Australia, Poland (TG-1701, Umbralisib, Ublituximab)

    Active, not recruiting
    • Non Hodgkin Lymphoma
    • Chronic Lymphocytic Leukemia
    • East Melbourne, Victoria, Australia
    • +7 more
    Jan 20, 2023

    Degenerative Disc Disease Trial (TG-C High Dose, TG-C Mid Dose, TG-C Low Dose)

    Not yet recruiting
    • Degenerative Disc Disease
    • TG-C High Dose
    • +3 more
    • (no location specified)
    Nov 17, 2023

    Familial Hypertriglyceridemia Trial (Heredity for cardiovascular disease, Heredity for pancreatitis, Heredity for type 2

    Active, not recruiting
    • Familial Hypertriglyceridemia
    • Heredity for cardiovascular disease
    • +3 more
    • (no location specified)
    Oct 23, 2023

    NAFLD, Type 2 Diabetes Trial in Aarhus N (High-fat mixed-meal tolerance test (HF-MMTT))

    Recruiting
    • NAFLD
    • Type 2 Diabetes
    • High-fat mixed-meal tolerance test (HF-MMTT)
    • Aarhus N, Denmark
      Department of Endocrinology and Internal Medicine
    May 23, 2022

    Hypertriglyceridemia, Cardiovascular Diseases, Atherosclerosis Trial in United States (Olezarsen, Placebo)

    Recruiting
    • Hypertriglyceridemia
    • +2 more
    • Birmingham, Alabama
    • +17 more
    Jan 26, 2023

    Hypertriglyceridemia, Atherosclerotic Cardiovascular Disease, Severe Hypertriglyceridemia Trial in Canada, United States

    Active, not recruiting
    • Hypertriglyceridemia
    • +2 more
    • Lincoln, California
    • +23 more
    Nov 23, 2022

    Postprandial Triglyceride and Glucose Responses

    Completed
    • Lipid Metabolism
    • Glucose Metabolism
    • Mixed meal challenge test
    • +4 more
    • Wageningen, Gelderland, Netherlands
      Stichting Wageningen Research
    Jul 4, 2022

    Splanchnic and Systemic VLDL-TG and FFA Balance

    Completed
    • NAFLD
    • NASH - Nonalcoholic Steatohepatitis
      • Skejby, Aarhus N, Denmark
        Arhus University Hospital Department of Endocrinology and Intern
      May 23, 2022